Saltar al contenido
Merck

Biomarkers of stress in behavioural medicine.

Current opinion in psychiatry (2013-07-23)
Urs M Nater, Nadine Skoluda, Jana Strahler
RESUMEN

In recent years, a growing interest has emerged in behavioural medicine to examine the role of acute and chronic stress as a predisposing and contributing factor to physical health and illness. For a deeper understanding of these associations, research is in need of biological markers for alterations in biological stress systems. This review will summarize a selection of important recent findings in this area of research. We will focus on essential peripheral stress-sensitive physiological systems, that is, the hypothalamic-pituitary-adrenal axis, the autonomic nervous system, and the immune system. We will present findings on commonly used stress biomarkers (cortisol, alpha-amylase, pro-inflammatory cytokines) regarding alterations in basal activity and stress-dependent reactivity in these systems, and discuss selected findings on intervention-induced changes of these biomarkers. This review will highlight new developments and guide readers in their choice of suitable study designs and outcomes in behavioural medicine. The reviewed studies included here encourage optimism that the employment of stress biomarkers in behavioural medicine has the potential to significantly improve our understanding of physical health and illness.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
αα-Amilasa from human saliva, Type XIII-A, lyophilized powder, 300-1,500 units/mg protein
Sigma-Aldrich
αα-amilasa from Bacillus sp., Type II-A, lyophilized powder, ≥1,500 units/mg protein (biuret)
Sigma-Aldrich
αα-Amilasa from human saliva, Type IX-A, lyophilized powder, 1,000-3,000 units/mg protein
Sigma-Aldrich
α-Amylase from Bacillus sp., powder, yellow-brown, ~50 U/mg
Sigma-Aldrich
αα-amilasa from Bacillus sp., powder, ≥400 units/mg protein (Lowry)
Sigma-Aldrich
α-Amylase from Bacillus sp., powder, yellow-brown, ~380 U/mg